Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | KDM3B | Q7LBC6 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | NAPRT | Q6XQN6 | 2/20 | 0.37 |
| ▸ | CSNK2A1 | P68400 | 3/20 | 0.37 |
| ▸ | CSNK2A2 | P19784 | 2/20 | 0.37 |
| ▸ | CSNK2B | P67870 | 2/20 | 0.37 |
| ▸ | GABRP | O00591 | 2/20 | 0.36 |
| ▸ | GABRD | O14764 | 2/20 | 0.36 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.36 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.36 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.36 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.36 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.36 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.36 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.36 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.36 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.36 |
| ▸ | GABRE | P78334 | 2/20 | 0.36 |
| ▸ | GABRA6 | Q16445 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21223630 | 0.87 | KDM3B (0.33) | KDM4EKDM3BTSHRNAPRTCSNK2A1 | |
| SCHEMBL7209768 | 0.84 | IKBKB (0.41) | KDM4ETSHRPIM3CLK4ALDH1A1 | |
| SCHEMBL9149637 | 0.83 | GABRP (0.33) | KDM4EKDM3BNAPRTGABRPGABRD | |
| SCHEMBL28361145 | 0.82 | PBRM1 (0.38) | KDM4ETSHRALDH1A1KMT2AADORA2A | |
| SCHEMBL10580660 | 0.79 | MAPT (0.47) | ALDH1A1KMT2AADORA1MEN1MAPT | |
| SCHEMBL532660 | 0.77 | — | — | |
| SCHEMBL932304 | 0.77 | — | — | |
| SCHEMBL3817207 | 0.77 | — | — | |
| SCHEMBL10401860 | 0.76 | KDM3B (0.44) | KDM4EKDM3BTSHRNAPRTCSNK2A1 | |
| SCHEMBL10401861 | 0.76 | KDM4E (0.40) | KDM4EKDM3BTSHRNAPRTCSNK2A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2304 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4747386-A1 | DOUBLE-STRANDED OLIGONUCLEOTIDE AGENTS AND USES THEREOF | Bisirna Therapeutics Pte. Ltd. (SG) | 2026-05-27 | — | — | EP | claimed |
| WO-2026106497-A2 | FUNCTIONALIZED CIRCULAR RNA AND METHODS AND INTERMEDIATES FOR THEIR PRODUCTION | SIEĆ BADAWCZA ŁUKASIEWICZ – PORT POLSKI OSRODEK ROZWOJU TECHNOLOGII (PL) | 2026-05-21 | — | — | WO | claimed |
| CN-122028913-A | Oligonucleotides containing ligands in nucleobases, 2 'or 3' positions | 阿达尔克斯制药有限公司 | 2026-05-12 | — | — | CN | claimed |
| CN-122029176-A | Containing a plurality of oligonucleotides modified oligonucleotides | 阿达尔克斯制药有限公司 | 2026-05-12 | — | — | CN | claimed |
| CN-122029177-A | Oligonucleotides containing multiple ligands and/or lipids | 阿达尔克斯制药有限公司 | 2026-05-12 | — | — | CN | claimed |
| US-20260125686-A1 | COMPOSITIONS AND METHODS FOR MODULATION OF CFTR | CYSTIC FIBROSIS FOUND (US) | 2026-05-07 | — | — | US | claimed |
| WO-2026090560-A1 | ENGINEERED NUCLEIC ACIDS AND USES THEREOF | CRANK BIO, INC. (US) | 2026-04-30 | — | — | WO | claimed |
| US-12606866-B2 | Methods for the amplification of bisulfite-treated DNA | THE UNIVERSITY OF CHICAGO (US) | 2026-04-21 | — | — | US | claimed |
| US-12601006-B2 | Targeted, long-read nucleic acid sequencing for the determination of cytosine modifications | LUDWIG INSTITUTE FOR CANCER RESEARCH LTD. (CH) | 2026-04-14 | — | — | US | claimed |
| EP-4713485-A2 | SEQUENCING ADAPTERS FOR METHYLATION SEQUENCING | Foundation Medicine, Inc. (US) | 2026-03-25 | — | — | EP | claimed |
| US-20140322707-A1 | COMPOSITION AND METHODS RELATED TO MODIFICATION OF 5-METHYLCYTOSINE (5-mC) | THE UNIVERSITY OF CHICAGO (US) | 2014-10-30 | — | — | US | claimed |
| EP-2791361-A1 | METHODS AND KITS FOR DETECTION OF METHYLATION STATUS | Oslo Universitetssykehus HF (NO) | 2014-10-22 | — | — | EP | claimed |
| EP-2768975-A1 | EPIGENETIC MARKER FOR THE IDENTIFICATION OF IL17 POSITIVE T CELLS IN COMPLEX SAMPLES | Epiontis GmbH (DE) | 2014-08-27 | — | — | EP | claimed |
| US-20140227703-A1 | EPIGENETIC MARKER FOR THE IDENTIFICATION OF IL17 POSITIVE T CELLS IN COMPLEX SAMPLES | EPIONTIS GMBH (DE) | 2014-08-14 | — | — | US | claimed |
| WO-2014074453-A1 | COMPOSITIONS AND METHODS FOR OXYGENATION OF NUCLEIC ACIDS CONTAINING 5-METHYLPYRIMIDINE | NEW ENGLAND BIOLABS, INC. (US) | 2014-05-15 | — | — | WO | claimed |
| WO-2014074450-A1 | MAPPING CYTOSINE MODIFICATIONS | NEW ENGLAND BIOLABS, INC. (US) | 2014-05-15 | — | — | WO | claimed |
| US-20130244237-A1 | Methods and Compositions for Discrimination Between Cytosine and Modifications Thereof and for Methylome Analysis | NEW ENGLAND BIOLABS, INC. (US) | 2013-09-19 | — | — | US | claimed |
| WO-2013138644-A2 | METHODS AND COMPOSITIONS FOR DISCRIMINATION BETWEEN CYTOSINE AND MODIFICATIONS THEREOF, AND FOR METHYLOME ANALYSIS | NEW ENGLAND BIOLABS, INC. (US) | 2013-09-19 | — | — | WO | claimed |
| WO-2013090588-A1 | METHODS AND KITS FOR DETECTION OF METHYLATION STATUS | OSLO UNIVERSITETSSYKEHUS HF (NO) | 2013-06-20 | — | — | WO | claimed |
| WO-2013057202-A1 | EPIGENETIC MARKER FOR THE IDENTIFICATION OF IL17 POSITIVE T CELLS IN COMPLEX SAMPLES | EPIONTIS GMBH (DE) | 2013-04-25 | — | — | WO | claimed |